 |  |  |  |
| Vendor/Item | Beckman Coulter, Inc Hemoccult® ICT Fecal Occult Blood Test | Beckman Coulter, Inc Hemoccult® II SENSA®elite Fecal Occult Blood Test | Beckman Coulter, Inc Hemoccult® SENSA® Fecal Occult Blood Test |
| List Price | Inquire | Inquire | Inquire |
| Request Information | Inquire | Inquire | Inquire |
| Catalog Number | Singles: 395065 | Triples: 395066 | 395035 | Singles: 64151 | Triples: 64130 |
| Description | Hemoccult® ICT is the latest and most advanced fecal occult blood test (FOBT) in the Hemoccult product line. An immunochemical FOBT (iFOBT) with high specificity and sensitivity, Hemoccult ICT is clinically proven to detect bleeding associated with more cancers and polyps ...
More... | Hemoccult II SENSA elite was designed to improve patient compliance. Its simplified test card, clearer patient instructions, and sample collection options make this fecal occult blood test easier for patients to understand and complete. Diet guidelines are explained in an ...
More... | Hemoccult SENSA fecal occult blood tests have been used with confidence in medical practice as a way to enhance detection of hidden blood in stool specimens, an early indication of colorectal cancer. Many recent studies show that annual screening with Hemoccult® will reduce ...
More... |
| Features | Better Healthcare
Clinically proven immunochemical FOBT
Human hemoglobin specific means fewer false positives
High sensitivity and specificity
Detects lower GI bleeding
Improved Compliance
No diet or drug restrictions ...
More... | Physicians’ #1 choice in enhanced fecal occult blood testing
Easier Diet and Patient Instructions
Easier Sample Collection
Easier ProcessingPrimary Care Diagnostics | Non-invasive, easy-to-use test is prepared in the privacy of the patient's home
Performance Monitor® area on each test offers built-in quality control
A variety of package configurations satisfies individual physician needs
Provides a low-cost ...
More... |
| Approval | US FDA, CLIA-Waived | US FDA CLIA-Waived | US FDA CLIA-Waived |
| Analysis Time | 5 minutes | 1 minute | 1 minute |
| Sample | Thin smear of fecal sample | Thin smear of fecal sample | Thin smear of fecal sample |
| Sensitivity | For colorectal cancer 90% | For colorectal cancer 92% | For colorectal cancer, 92% |
| Instrumentation Needed | None | No | No |
| Cutoff | 0.3 mg Hb/g feces | 0.3 mg Hb/g feces | 0.3 mg Hb/g feces |
| Specificity | For lower GI bleeding 99.1% | For colorectal cancer 96.5% | For colorectal cancer, 96.5% |
| Units/Range | Qualitative | Qualitative | Qualitative |
| Storage/Stability | 2-8°C until exipiration date or 15 to 30 °C for 30 days or until expiration date, whichever comes first /Sample: 14 days | 15 to 30°C /Sample: 14 days | 15 to 30°C until expiration date/Sample: 14 days |
| Test Method | Immunochemical – Human Hemoglobin Antibody | Guaiac-based fecal occult blood test | Guaiac-based fecal occult blood test |
| More Information | Product Information | Product Information | Product Information |
| More Products | Related Products | Related Products | Related Products |
